Candel Therapeutics Announces Pricing of Initial Public Offering
July 26, 2021 21:05 ET
|
Candel Therapeutics
NEEDHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”), a late clinical stage biopharmaceutical company developing novel oncolytic viral immunotherapies, today...
Candel Therapeutics Completes $28.7 Million Series B Financing
January 04, 2019 14:33 ET
|
Candel Therapeutics
Proceeds to Accelerate Enrollment of Phase 3 Localized Prostate Cancer Clinical Trial and to Advance Late Stage High-Grade Glioma Clinical Program Candel to Expand Clinical Trials in Other...
Advantagene Announces Clinical Trial Collaboration
April 27, 2018 07:00 ET
|
Advantagene, Inc.
AUBURNDALE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Advantagene, Inc. today announced that the company entered into a clinical trial collaboration with Bristol-Myers Squibb (NYSE:BMY) to evaluate...